Cargando…
Efficacy and Safety of Cetuximab Plus Cisplatin Alone or in Combination With Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma: A Randomized Trial
OBJECTIVES: The aim of this study was to assess the clinical usefulness of cetuximab and cisplatin alone or in combination with paclitaxel as the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). METHODOLOGY: Three hundred patients with conf...
Autores principales: | Zheng, Yanqing, Dou, Huiqin, Li, Qingchen, Sun, Ying, Wang, Yanchao, Zhang, Wendong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204453/ https://www.ncbi.nlm.nih.gov/pubmed/34029149 http://dx.doi.org/10.1177/1073274821997444 |
Ejemplares similares
-
Ultrasound Parameters of Thyroid Nodules and the Risk of Malignancy:
A Retrospective Analysis
por: Wang, Minxin, et al.
Publicado: (2020) -
The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
por: Huiskamp, L. F. J., et al.
Publicado: (2020) -
A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers
por: Noronha, Vanita, et al.
Publicado: (2017) -
Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018) -
Body composition analysis in head and neck squamous cell carcinoma
por: Malecka-Massalska, Teresa, et al.
Publicado: (2013)